HC Wainwright Reiterates Buy Rating for Ekso Bionics (NASDAQ:EKSO)

Ekso Bionics (NASDAQ:EKSO)‘s stock had its “buy” rating reaffirmed by analysts at HC Wainwright in a research report issued on Tuesday,Benzinga reports. They currently have a $9.00 target price on the stock.

Several other equities analysts also recently commented on EKSO. Lake Street Capital cut their target price on Ekso Bionics from $2.50 to $2.00 and set a “buy” rating for the company in a research report on Tuesday, October 29th. StockNews.com initiated coverage on shares of Ekso Bionics in a research note on Tuesday. They issued a “hold” rating on the stock.

Ekso Bionics Trading Down 9.7 %

Shares of EKSO opened at $0.71 on Tuesday. The stock’s 50-day moving average price is $0.70 and its 200 day moving average price is $0.96. The company has a quick ratio of 2.14, a current ratio of 2.81 and a debt-to-equity ratio of 0.28. Ekso Bionics has a 12-month low of $0.50 and a 12-month high of $2.50. The firm has a market capitalization of $15.66 million, a price-to-earnings ratio of -1.10 and a beta of 1.47.

Ekso Bionics (NASDAQ:EKSO) last posted its quarterly earnings results on Monday, October 28th. The company reported ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.02). Ekso Bionics had a negative return on equity of 83.09% and a negative net margin of 62.95%. The business had revenue of $4.13 million for the quarter, compared to analyst estimates of $6.00 million. During the same quarter in the prior year, the firm earned ($0.24) EPS. As a group, research analysts predict that Ekso Bionics will post -0.48 earnings per share for the current year.

About Ekso Bionics

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.